Euractiv (Advocacy Lab)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EUROPEAN BIOTECHNOLOGY MAGAZINE - The COVID-19 pandemic transformed RNA technologies into one of the most visible scientific breakthroughs of the decade. mRNA vaccines demonstrated unprecedented speed of development, large-scale manufacturing capability and global deployment, pushing RNA therapeutics into the public spotlight. But according to...
EU PERSPECTIVES - When it comes to cancer medicines, the EU should look beyond a purely 'Made in Europe' approach and embrace 'Made with Europe', according to Giancarlo Benelli, Head of Europe at BeOne Medicines. "Cancer does not have borders," he says, as many European patients still wait too long for innovative treatments. He argues that...
EU PERSPECTIVES - How can Europe attract more doctors, nurses and other healthcare workers — and, crucially, keep them in the profession? As staff shortages deepen across the bloc, the European Parliament has backed a plan to recruit at least one million people over the next seven years. But lawmakers face a growing dilemma: how to fill the...
EU PERSPECTIVES - The Ebola outbreak in Africa is becoming more than a public health emergency. As EU ministers meet to coordinate their response, the European Commission is presenting the crisis as evidence that Europe must invest more heavily in preparedness, vaccines and medical countermeasures before the next outbreak arrives. Read more
